Iran vs France vaccination coverage (% of children aged 12–23 months)
Measles, first dose (MCV1)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 99% | 95% |
| 2023 | 99% | 95% |
| 2022 | 99% | 95% |
| 2021 | 99% | 94% |
| 2020 | 99% | 94% |
| 2019 | 99% | 92% |
| 2018 | 99% | 91% |
| 2017 | 99% | 90% |
| 2016 | 99% | 90% |
| 2015 | 99% | 91% |
| 2014 | 99% | 91% |
| 2013 | 98% | 90% |
| 2012 | 98% | 91% |
| 2011 | 99% | 89% |
| 2010 | 99% | 89% |
| 2009 | 99% | 89% |
| 2008 | 98% | 89% |
| 2007 | 97% | 90% |
| 2006 | 99% | 89% |
| 2005 | 94% | 87% |
| 2004 | 96% | 88% |
| 2003 | 99% | 87% |
| 2002 | 99% | 86% |
| 2001 | 96% | 85% |
| 2000 | 99% | 84% |
| 1999 | 99% | 83% |
| 1998 | 99% | 82% |
| 1997 | 95% | 83% |
| 1996 | 99% | 84% |
| 1995 | 95% | 83% |
| 1994 | 97% | 80% |
| 1993 | 96% | 78% |
| 1992 | 96% | 76% |
| 1991 | 84% | 74% |
| 1990 | 85% | 71% |
| 1989 | 79% | 58% |
| 1988 | 83% | 51% |
| 1987 | 55% | 45% |
| 1986 | 55% | 39% |
| 1985 | 62% | 35% |
| 1984 | 38% | 26% |
| 1983 | 38% | 15% |
| 1982 | 55% | - |
| 1981 | 48% | - |
| 1980 | 39% | - |
DTP3 (diphtheria, tetanus, whooping cough; third dose)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 98% | 96% |
| 2023 | 99% | 96% |
| 2022 | 99% | 96% |
| 2021 | 98% | 96% |
| 2020 | 99% | 96% |
| 2019 | 99% | 95% |
| 2018 | 99% | 95% |
| 2017 | 99% | 95% |
| 2016 | 99% | 95% |
| 2015 | 98% | 96% |
| 2014 | 99% | 92% |
| 2013 | 98% | 88% |
| 2012 | 99% | 99% |
| 2011 | 99% | 99% |
| 2010 | 99% | 99% |
| 2009 | 99% | 98% |
| 2008 | 99% | 99% |
| 2007 | 99% | 99% |
| 2006 | 98% | 99% |
| 2005 | 95% | 98% |
| 2004 | 99% | 98% |
| 2003 | 99% | 97% |
| 2002 | 99% | 97% |
| 2001 | 96% | 97% |
| 2000 | 99% | 97% |
| 1999 | 99% | 97% |
| 1998 | 99% | 96% |
| 1997 | 99% | 97% |
| 1996 | 99% | 97% |
| 1995 | 98% | 96% |
| 1994 | 95% | 96% |
| 1993 | 99% | 94% |
| 1992 | 97% | 94% |
| 1991 | 88% | 94% |
| 1990 | 91% | 94% |
| 1989 | 82% | 95% |
| 1988 | 88% | 79% |
| 1987 | 57% | 88% |
| 1986 | 57% | 96% |
| 1985 | 51% | 95% |
| 1984 | 33% | 94% |
| 1983 | 33% | 90% |
| 1982 | 41% | 85% |
| 1981 | 29% | 79% |
| 1980 | 32% | 79% |
Hepatitis B, third dose (HepB3)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 98% | 96% |
| 2023 | 99% | 96% |
| 2022 | 99% | 96% |
| 2021 | 98% | 96% |
| 2020 | 99% | 95% |
| 2019 | 99% | 92% |
| 2018 | 99% | 90% |
| 2017 | 99% | 91% |
| 2016 | 99% | 90% |
| 2015 | 98% | 88% |
| 2014 | 99% | 83% |
| 2013 | 99% | 82% |
| 2012 | 98% | 78% |
| 2011 | 99% | 74% |
| 2010 | 99% | 64% |
| 2009 | 99% | 51% |
| 2008 | 99% | 47% |
| 2007 | 97% | 42% |
| 2006 | 98% | 39% |
| 2005 | 94% | 35% |
| 2004 | 95% | 35% |
| 2003 | 98% | 28% |
| 2002 | 99% | 29% |
| 2001 | 94% | 28% |
| 2000 | 99% | 26% |
| 1999 | 95% | 24% |
| 1998 | 94% | 27% |
| 1997 | 93% | - |
| 1996 | 84% | - |
| 1995 | 59% | - |
| 1994 | 62% | - |
| 1993 | - | - |
| 1992 | - | - |
| 1991 | - | - |
| 1990 | - | - |
| 1989 | - | - |
| 1988 | - | - |
| 1987 | - | - |
| 1986 | - | - |
| 1985 | - | - |
| 1984 | - | - |
| 1983 | - | - |
| 1982 | - | - |
| 1981 | - | - |
| 1980 | - | - |
The first measles dose reaches 99% of children aged 12–23 months in Iran and 95% in France: 4 percentage points more in Iran. The third DTP dose reaches 98% in Iran and 96% in France, 2 points more in Iran. The third hepatitis B dose reaches 98% in Iran and 96% in France, 2 points more in Iran. In 1983, the first measles dose reached 38% in Iran and 15% in France, 23 percentage points more in Iran.
Iran vs France: latest vaccination coverage (% of children aged 12–23 months)
|
|
|
|
|---|---|---|
| Measles (MCV1) | 99% (2024) | 95% (2024) |
| DTP3 | 98% (2024) | 96% (2024) |
| HepB3 | 98% (2024) | 96% (2024) |
Iran and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
France and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Of Iran and its seven neighbors, the latest coverage of the first measles dose is highest in Iran, at 99%, and lowest in Afghanistan, at 55%; of France and its eight neighbors, the latest coverage of the first measles dose is highest in Luxembourg, at 99%, and lowest in Monaco, at 88%.
Compare the vaccination rates of any 2 countries
Sources:
- World Bank | Health (1980–2024, updated October 2026)
Creative Commons Attribution (CC BY): you may copy, share, adapt and reuse this content, also commercially, as long as you credit statistics.wiki and note any changes you made. The sources listed above may have their own license terms.